JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1968) 40, 253-254    DOI: 10.1677/joe.0.0400253
© 1968 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ARGÜELLES, A. E.
Right arrow Articles by POGGI, U. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ARGÜELLES, A. E.
Right arrow Articles by POGGI, U. L.

EFFECT OF METYRAPONE ON THE EXCRETION OF OESTROGEN IN MAN

A. E. ARGÜELLES, H. MARTÍ, C. SABORIDA and U. L. POGGI

Hydroxylation at the angular C-19 methyl group is thought to be a necessary step for the biosynthesis of oestrogens since it is the first stage of aromatization (Meyer, 1955; Ryan, 1959).

Griffiths (1963) found that the dose of metyrapone which produced an inhibition of 11β-hydroxylase activity in the adrenal of the golden hamster also produced a decrease in the activity of the 19-hydroxylase. This indicated the use of metyrapone as an inhibitor of oestrogen biosynthesis. Földes, Koref, Fehér & Steczek (1964) suggested that metyrapone affects the adrenal and the ovary; they reported a decrease in the excretion of oestrone, 17β-oestradiol and oestriol with a particularly marked decrease of the oestradiol fraction, both on the day of treatment and on the day after. The same authors refer to a simultaneous increase of androsterone and aetiocholanolone originating possibly from androst-4-ene-3,17-dione, the concentration of which may increase with the decreased formation of 19







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1968 by the Society for Endocrinology.